James Investment Research Inc Palatin Technologies Inc Transaction History

James Investment Research Inc

  • $819 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022
SELL
$0.34 - $0.86 $2,433 - $6,155
-7,158 Reduced 5.92%
113,782 $58,000
Q2 2021

Jul 26, 2021
SELL
$0.48 - $0.72 $4,348 - $6,523
-9,060 Reduced 6.97%
120,940 $74,000
Q1 2021

Apr 22, 2021
BUY
$0.68 - $1.25 $20,400 - $37,500
30,000 Added 30.0%
130,000 $89,000
Q3 2020

Oct 23, 2020
BUY
$0.47 - $0.64 $47,000 - $64,000
100,000 New
100,000 $47,000

Others Institutions Holding PTN

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0
View Full List

About PALATIN TECHNOLOGIES INC

PTN Quotes by TradingView
  • Ticker PTN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,290,480
  • Market Cap $10.4M
  • Description
  • Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...
More about PTN
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email